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Abstract 
We seek to understand which firms excel at innovation and commercialization. In doing so, we first ranked 
companies that performed well on four measures: spending on R & D Spending (2006), Patenting (cumula-
tive 2006 and 2007) and Commercialization of Innovations (cumulative for 2007 and 2008). We then com-
pared our rankings with that of Business Week/Boston Consulting Group’s annual ranking of the most innova-
tive companies, which primarily is based on reputation measured as perceptions among sitting CEO’s. Some-
what surprisingly, there is not complete overlap between our more quantitative ranking and the one done by 
Business Week/BCG, and we highlight the reasons why. Second, we tested the relationship among R & D, 
patents, and product releases and the role they play in driving revenue. We found that although innovation and
commercialization are different, they need to be considered together, that perceptions and reality in this realm 
often do not match, and that joint innovation and commercialization activities can influence the bottom line. 
Keywords: R & D, Patents, Technology, Investment, Product Releases, Commercialization of Innovation, 
Revenues
1. Introduction 
To survive firms must continue to innovate and success-
fully commercialize these innovations, whether by cre-
ating significant improvements to existing products in
order to maintain or grow market share, or by creating
entirely new products that potentially drive new markets 
[1-4]. With increasing globalization, environmental com-
plexity, economic uncertainty, intense competition and
pressure to perform that ensues, means that the need to 
bring innovations to market successfully is greater than 
ever. As a result, research on and rankings of the world’s
most innovative companies, and how they achieve this 
status, is useful and timely in a variety of ways. Despite
the recognition of the importance of commercialization 
of innovations within the general management literature, 
[1-4], the research activities within the reputation litera-
have generally ignored innovation and ture commer-
cialization. 
Further, popular rankings of firms based on their in-
novative capabilities has been done primarily using 
measures based on the perceptions of CEO’s rather than 
using measures of definitive activities and hard outcomes
within firms. We feel there is need for a better under-
standing of the role that innovation and commercializa-
tion play in firm success. 
2. Research on, and Rankings of, Firms That 
Are Good at Innovation 
A number of books in the popular business press have
been written in recent years with prescriptions for how 
firms can be innovative. They tend to be based more on
the qualitative, anecdotal experiences that the authors 
have had with relatively limited sets of companies. 
Nonetheless, they are helpful insofar they offer useful
suggestions for what might work and what might not
work in specific types of companies. Beyond that, there 
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is a need for research that systematically looks across
many firms and helps us to understand with greater con-
fidence exactly how the good firms innovate. Toward
this end, Business Week, together with the Boston Con-
sulting Group, began publishing their annual ranking of 
the top innovative firms. Their ranking looks across a 
wide variety of firms and is based on a survey of sitting 
executives and who they perceive to be the most innova-
tive firms. Their ranking thus tells us who has the best
reputation for innovation among active CEOs. 
3. What Does It Mean to Be an Innovative 
Company? 
We seek to build on existing research and understand 
which firms are best at innovating, and why. More to the 
point, we seek to understand why some firms are better
at commercializing innovations than are others, because
a firm can be innovative and not necessarily be success-
ful. There exist a set of specific characteristics within 
firms, together with a set of environmental factors that
serve to either enable or inhibit firms in their efforts to
commercialize innovation. Below we highlight a short- 
list of those factors that we believe are the best indicators 
of whether or not a firm is successfully commercializing 
innovation; that is, what are they actually doing that
helps them continually to commercialize innovations. 
Firms that are the best at commercializing innovation 
over time are very good at maximizing their innovation 
chain. We define the innovation chain as the sequence of
events in a firm that include spending on research and
development, protecting intellectual property (e.g., patent
protection), launching new products and/or services, and 
consequently performing well financially. 
3.1. The Innovation Chain (Figure 1)
Firms must continue to successfully innovate and com-
mercialize these innovations whether by creating new 
products and services that drive new markets or by cre-
ating innovations that enable them to hold on to niches in 
existing markets [1-4]. It is often a mistake to assume
that innovation is limited to product innovation driven by
R & D. Other means of innovation, for example, include
firms improving efficiency by continually looking for
ways to run themselves better, which has been defined
by others as continuous process innovation. Similarly,
firms can “acquire” innovation via mergers, acquisitions, 
and joint ventures with other firms that possess innova-
tive products, services, technologies, and other forms of
intellectual property. This can be particularly useful in a 
situation where a firm needs to be in a specific market 
quickly and does not have sufficient time to develop its 
own capabilities and corresponding products for that new 
market opportunity. All these are examples of ways that
a firm can be innovative, but they do not necessarily
represent the extent to which a firm is successful at con-
tinually commercializing innovations over time. 
Similarly, the economic conditions within which a 
firm operates can influence a firm’s ability to innovate 
and commercialize. Poor economic conditions, for ex-
ample, may make it difficult to acquire the capital nec-
essary to develop new products, or may cause customers 
to choose to hold back on their purchases and not buy the 
innovative new products that companies are producing.
We believe that these macro-level economic factors are
important, but they do not tell us about a firm’s core in-
novation chain and related capabilities. We therefore 
hold them constant. 
3.1.1. Commercialization 
The commercialization of innovations involves the act of
bringing innovations and to market [2,5-9]. Past research
has also posited that successful commercialization of
innovation is necessary in order for firms to be competi-
tive [2,10], and is necessary to advance the economy at 
Research & 
Development 
Patent 
Protection 
New Product 
and Service 
Offerings 
Financial 
Performance 
Continuous Process Innovations 
Mergers, Acquisitions and Joint 
Ventures 
Macro Economic Conditions 
Figure 1. Innovation chain. 
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large [1,3,4,11]. “New product introduction is an impor-
tant measure of innovativeness, because it indicates the
potential commercial significance of a firm’s innovation 
activities” [12,13]. 
Innovation cannot influence firm performance until 
the ideas have been introduced to the market [12]. In 
other words, an innovation “ideated” in a firm can only
become a successful innovation if it has a marketable use 
[14]. Past research has shown that innovation ideation
does not always automatically lead to innovation com-
mercialization [15,16]. Firms depend on products and
services developed three to five years ago for large por-
tions of their current sales and as a result can find them-
selves aiming at an elusive target that is years in the fu-
ture as they try to compete in a marketplace today [2,17]. 
Most single innovations can be duplicated and so just
being innovative does not guarantee a sustained competi-
tive advantage. However, innovations are harder to imi-
tate if they are successfully commercialized followed by
successive innovations in the area. While the literature
links firm innovations with firm performance, we propose
that innovation in its solitary state cannot achieve an ad-
vantage that is sustainable. Rather, it is commercializa-
tion followed by successive evolutionary innovation that
leads to sustained competitive advantage for a firm. 
3.1.2. R & D Activities
The importance of R & D, for both internally developed 
and capitalizing on externally acquired innovations, is 
well established and well understood. Beyond that re-
search on what R & D means to the firm is wide ranging.
For example, firms are continuously looking into ways to
reduce R & D costs, while not reducing the R & D ac-
tivities [18], and relatedly, universities impact industrial 
R & D through several channels [19]. A firm’s geo-
graphic location, alliances with other institutions and 
organizations and R & D expenditures are representative
of knowledge flows, while products in the pipeline, firm 
citations and patents are indicative of knowledge stocks
[20]. Dutta & Weiss (1997) linked technological innova-
tiveness with partnership agreements. Their sample of 
technologically innovative companies were proxied from
companies that invested heavily in R & D [21]. R & D
spillovers are, potentially, a major source of innovation
[22]. During times of austerity firms must tighten their 
belts, subject nascent product-development programs to
rigorous screening, and train R & D staffers to think in 
business terms so they will be better able to decide
whether an idea for a product or service is worth pursu-
ing in the first place [23]. International diversification is
also positively related to R & D intensity [24]. Based on
between R & D and a firm’s inventive activities [25]. 
a study of 137 Japanese firms, a positive link was found 
Firms often conduct international R & D to tap into 
knowledge bases that reside in foreign countries [26]. 
Penner-Hahn and Shaver argued that in order to benefit
from international R & D investments, firms must al-
ready possess research capabilities in underlying or 
complementary technologies. Also, R & D intensity is a
positive moderator between exploration and exploitation 
and environmental conditions [27]. Finally, stage of the
R & D process moderates the relationship between the
wealth effects, technology, and market variables [5]. 
3.1.3. Patenting
Patents are physical, codifiable manifestations of innova-
tive ideas that embody the knowledge of one or several
employees [20]. Patents often have been used as a proxy
for innovations. It has been measured as: patents as in-
ventions [20,28,29], patents as a solution to a technical
problem [12], patents as firm knowledge [20,29], patents
as firm technological knowledge [14], patents as firm
technological innovation [21], and patents as innovative 
output [26].
Patents are seen as a reliable indicator of a firm’s in-
termediate innovation-output [26]. Consequently, they 
have been extensively used in several empirical studies
in strategy and economics as a means to capture a firm’s 
intermediate innovative output and substantiate a firm’s 
innovation ideation. Patents have been used as a proxy
for invention outcomes, which has been modeled to pre-
cede innovation commercialization [2,28]. Patents have
been used as an indicator to measure firm’s new knowl-
edge creation efforts and its impact on future innovative 
outcomes [14]. They have also been used to measure the
stock of innovative knowledge held by a firm [18,20]. In
addition, patents have been used to reflect production of 
ideas at a country level [30,31]. 
Knowledge embodied in patents represents significant
and important innovations that can be commercialized 
into new products or services with potential financial 
returns. Patents allow us to better capture the outcome, 
effort and activities of innovative knowledge creation,
and they increase the potential returns of commercializa-
tion. Thus, patents are widely accepted measures by pol-
icy makers and analysts [32] in terms of technology
strategy and competitive analysis. 
3.1.4. Financial Performance
Briefly, financial performance has been measured as
accounting or market based measures. For example some 
of the firm performance measures used for R & D, patents, 
and product launches were, return on assets, return on
sales, stock return, sales growth or profit margin, revenue,
and market value [20,24,28,33]. Market measures also
have included, cumulative abnormal-return [34]. 
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4. Methods 
4.1. Data Collection 
Guided by prior research, as embedded in our visualiza-
tion of the innovation chain, we gathered data on: 1)
corporate spending on research and development, 2)
protection of intellectual property, 3) new product and/or
service launches, and 4) financial performance, and we
chose for this initial analysis simply to look at revenues 
given that they are more an indicator of consumers’ de-
mand and desire for a particular firm’s products, as op-
posed to a measure such as profits that would also indi-
cate a firm’s capability to manage itself well. We were 
interested in determining not only which firms are the 
best within each category but, more importantly, which 
of them are the best overall, which we take as a proxy for
successful commercialization of innovation. While we 
believe that there are other factors that influence a firm’s 
ability to commercialize innovation, such as continuous
process innovation, mergers, acquisitions, joint ventures,
and macro economic conditions, we focused our analysis 
on the core processes that we believe comprise the inno-
vation chain. We did not restrict ourselves to only the
Fortune 1000-firms, thus our list includes foreign firms 
operating in US. 
For R & D we collected data on overall spending of 
firms on research and development in U.S. dollars for the 
year 2007 from Fortune’s annual data on R & D spend-
ing. We collected data on revenues for American corpo-
rations from the Fortune 1000 lists for the period 2008.
For organizations outside the US we created a list of
those international firms that do well on our three prior 
measures and then used other sources (such as their own 
performance reports) to ascertain their annual sales
revenues.
For patents we collected data from the U.S. Patent Of-
fice Web site that shows all submissions for patents from
companies during the years 2006 and 2007. For product
launches (commercialization of innovations) we col-
lected data on product launches directly from corporate
Web sites where we found formal announcements such
as dated press releases. We agreed on a protocol for cap-
turing these announcements, and then one of our three 
authors captured the announcements and a second author 
checked them for accuracy and consistency. We tracked 
formal press releases announcing the release of new 
products and/or services (including significant product/
service enhancements) for the year 2007, and 2008. We
aggregated the number of new products and services
introduced to the market by a firm over two-periods from
to measure commercialized innovation. 
2007 (considering a one-year lag to patent applications) 
Appendix 1 shows the data we collected within each
of the four categories and the overlap with the Business 
Week/BCG rankings. 
4.2. Statistical Tests 
For the purpose of this paper we needed to see the com-
pactness among three of the three dimensions of innova-
tiveness: R & D spending (2006), Patenting (cumulative 
2006 and 2007) and Commercialization of Innovations 
(Cumulative for 2007 and 2008). We also needed to see
the impact of those three variables on Revenues for year 
2008, 2009 and 2010. We thus needed to estimate a sys-
tem of equations. In such cases, two stage least squares 
regression (2SLS) and Path Modeling (a variant of Struc-
tural Equation model) are both feasible approaches to 
account for the potential for correlation in the errors
across estimated equations [35]. We used Structural Equa-
tion Modeling (SEM) with no latent variables to test our 
research model. Compared to a 2SLS, path modeling pro-
vides a better approach to test our model by allowing us
to better assess the simultaneous effect of all the variables.
5. Findings 
5.1. Statistical Tests 
Figure 2 and Table 1 show the results of the statistical 
analysis. R & D explains variance in number of patents
(R2 = 0.085; β = 0.292; p < 0.05) and commercialized
innovations (R2 = 0.025; β = 0.183; p < 0.05). Further, as
expected the number of patents also explains variance on 
commercialized innovations (R2 = 0.025; β = 0.183; p <
0.05). Thus, also as expected the three of the four dimen-
sions of innovations were linked. 
The relation of these three variables (R & D, Patents,
and commercialized innovations (CI) with respect to
revenues is more complicated. The collective impact of 
R & D, Patents, and CI on revenues for the years, 2008, 
2009 and 2010 are R2 = 0.350 (p < 0.001), R2 = 0.248 (p
< 0.001), and R2 = 0.266 (p < 0.001), respectively. While
the three variables collectively explain variance in reve-
nue, the paths from Patents and CI to revenue remained
non-significant. An interesting observation is that as we 
moved revenues from 2008 through 2010, while the col-
lective explanatory power decreased, the explanatory
power of CI and Patents on Revenues increased. For in-
stance the path coefficients from patents to revenue, 
despite remaining non-significant, increased from β = 
0.019 in 2008 to β = 0.020 in 2009 to β = 0.132 in 2010. 
Similarly, the path coefficients from CI to revenue in-
creased from β = 0.075 in 2008 to β = 0.127 in 2009 to β
= 0.135 in 2010. An explanation for this is that R & D
TI
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Revenue at Year 1: R(Y) 
R2= .350** 
β=.616** (from R&D) 
β=.019 Non‐Sig (From patents) 
β=.075 Non‐Sig (from 
Commercialized Innovations) 
Revenue at Year 2: R(Y+1) 
R2=.248** 
β=.501** 
β=.020 Non‐Sig (From patents) 
Β=.127 Non‐Sig (from 
Commercialized Innovations) 
Revenue at Year 3: R(Y+2) 
R2=.266** 
β=.484** 
β=. 132 Non‐Sig (From patents) 
β=. 135 Non‐Sig (from 
Commercialized Innovations) 
β= 
R&D Spending 
No of patents 
R2=.085* 
Commercialized 
innovations 
R2=.025* (from R&D) 
R2= .089* (from patents) 
β=.292* 
.183* 
β= .299* 
*p<. 05; **p<.001 
Figure 2. Variance model with statistical results. 
Table 1. Results of the regressions.
Antecedents Consequents R2 Path Beta 
R & D Patents (P)
R & D Commercialized innovations (CI) 
Patents (P) Commercialized Innovations (CI) 
R & D, P, CI Revenue Year (Y) 
R & D, P, CI Revenue Year (Y + 1)
R & D, P, CI Revenue Year (Y + 2)
*p < 0.05; **p < 0.001.
and revenues are highly correlated and there is a lag time
from R & D spending to patents and from patents to
commercialized products. Also, per extant research there
is a lag time between product release and diffusion of the
product into the market [36]. These lag times impact the
effect of patents and subsequently CI on revenues. Al-
though insignificant early on, the impact of patents and
CI on revenues increases in subsequent years when
products diffuse in the market. 
0.085* R & D  P 0.292* 
0.025* R & D  CI 0.183* 
0.089* P  CI 0.299* 
R & D  R(Y) 0.616** 
0.350** P  R(Y) 0.019 (Non-Sig)
CI  R(Y) 0.075 (Non-Sig)
R & D  R(Y + 1) 0.510** 
0.248** P  R(Y + 1) 0.020 (Non-Sig)
CI  R(Y + 1) 0.127 (Non-Sig)
R & D  R(Y + 1) 0.484** 
0.266** P  R(Y + 1) 0.132 (Non-Sig)
CI  R(Y + 1) 0.135 (Non-Sig)
5.2. A Deeper Look at the Most Innovative 
Firms 
5.2.1. Who Are Spending the Most on R & D?
The top ten R & D spenders were, in order: Pfizer, Ford, 
Johnson & Johnson, DaimlerChrysler, Toyota Motor, 
GlaxoSmithKline, General Motors, Seimens, Microsoft, 
and Samsung Electronics. These firms represent a variety 
of industries, though one industry (automobile manufac-
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turing) has four of the top ten spots. These ten firms also 
spent in excess of $68 billion on research and develop-
ment that year. Surprisingly, there is only a 44% overlap 
between this list of top R & D spenders and the Busi-
nessWeek/BCG list of top innovators. Some of the top R
& D spenders not ranked by BusinessWeek were, Erics-
son (now Sony Ericsson), Matsushita Electric (now 
Panasonic Corporation), Texas Instruments, Nissan, Hi-
tachi, Renault, Sun Microsystems, and Toshiba. Appar-
ently, heavy spending on R & D does not necessarily
translate perfectly into perceptions among sitting CEOs 
that a company is a top innovator. 
5.2.2. Who Had the Most Patent Submissions?
The top ten firms for patent submissions for that period
were IBM, Samsung Electronics, Canon, Matsushita
Electric (Panasonic Corporation), Intel, Microsoft, To-
shiba, Micron Technology, Hewlett Packard, and Sony, 
respectively. These top ten firms submitted applications
for over 19,000 patents during that time period. IBM
alone submitted over 3000 patents. This list clearly is 
dominated by electronics manufacturers. As with R & D 
spending, we found a 40% overlap with the Business
Week/BCG ranking on the dimension of patent protec-
tion. Some of the prominent organizations not present in
the ranking by BusinessWeek/BCG were Canon, Matsu-
shita, Micron Technology, Hitachi, and Texas Instru-
ments.
5.2.3. Who Had the Most Product Launches?
The top ten for firms releasing new products and/or ser-
vices for that time period includes Microsoft, LG Elec-
tronics, Fujitso, Freescale Semiconductor, Toshiba, Hew-
lett Packard, Texas Instruments, Samsung Electronics, 
STMicroelectronics, and Sharp Kabushiki Kaisha (Sharp
Corporation), respectively. These top ten firms formally
announced the release of over 1900 new products and/or
services during that time period- a high number consid-
ering that these came from only ten firms. As with patent
submissions this list is dominated by electronics manu-
facturers.  
There is also only a 38% overlap between our list on
new product/service launches and that of BusinessWeek/
BCG. Among the more prominent firms on our list that 
are not ranked by BusinessWeek/BCG are, Fujitso, To-
shiba, Sharp, Oracle, Dow Chemical, Sun Microsystems,
Seiko Epson Corporation, Matsushita, and GlaxoSmith-
Kline. Given that among the three measures we’ve dis-
cussed above this measure of new product/service 
launches is perhaps the most visible and public of the
this measure and the Business Week/BCG ranking is so
three, it is surprising that the degree of overlap between 
low in the absolute sense and has the lowest overlap of
our three measures thus far. The CEO’s surveyed by
Business Week/BCG as to their perceptions of the top 
innovators is not influenced by public product and ser-
vice launches as much as may be expected. 
5.2.4. Who Are Generating the Most Revenue? 
The top ten firms in revenue generation for this time pe-
riod include BP, Wal-Mart, Exxon Mobile, General Mo-
tors, DaimlerChrysler, Toyota Motor, GE, Ford, Volks-
wagen, and Seimens. These top ten firms generated over 
$2260 billion during time period for the study. Interest-
ingly, this list is dominated by five automobile manufac-
turers. There is a 48% overlap with the BusinessWeek/
BCG ranking, suggesting that financial performance is
perhaps weighted higher than are other capabilities in the 
minds of sitting CEOs as they rank the top innovators. 
Some of the most prominent firms on our revenue list 
that are not ranked by BusinessWeek/BCG were, Nissan 
Motors, British Petroleum, Siemens, Nestle, Matsushita, 
Toshiba, Unilever, Dow Chemical, and GlaxoSmith-
Kline. 
5.2.5. Which Firms Did Well on All Four Attributes? 
Recall that our belief is that you must look at how well 
firms are actually commercializing innovations. That
means you must look at the actual activities that a firm 
engages in that enable commercialization, which we de-
scribe as the innovation chain and is comprised of R & D
spending, patent protection, new product/service launches, 
and revenues. Appendix 2 shows the positioning of firms 
on each of these four dimensions. Each of the columns 
shows the ranking of the top 50 firms on that particular 
dimension, and the grey-scale coding within that table
represents how many of the columns that firm appears.
Firms coded in dark grey appeared in the top 50 within
all four categories. Firms coded in one shade lighter grey
are in the top 50 within three categories. Firms in two
shades lighter grey appeared in two categories, and firms 
in white appeared in one category. Appendix 3 shows
which firms appeared in all four categories, a total of 15 
firms. It also shows which firms appeared in three of the
four categories, a total of 16 firms. The 15 firms that 
performed well on all four aspects of the innovation
chain invested heavily in research and development,
worked hard to protect their intellectual property in the
form of patent submissions, launched a relatively high
number of new products and/or services, or at least re-
leased a relatively high number of significant upgrades
and enhancements to their offerings, and also generated a 
large amount of revenues. We list these firms alphabeti-
cally and purposefully do not make any judgments about
the relative rankings within this list of 15. We believe
that all of these 15 can be thought of as great innovators 
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and commercializers of their innovations. Given that
they represent diverse industries, and thus have to con-
tend with different economic and environmental factors,
it would be difficult to make meaningful comparisons. It
is worth noting, however, that these 15 firms are domi-
nated by 10 electronics manufacturers of various types,
with an additional 3 automobile manufacturers, 1 aircraft
manufacturer, and 1 software firm. Of these 15 firms, 7
came from the USA (2 from Washington State, 2 from
Michigan, 1 from Illinois, 1 from New York and 1 from
California), 5 from Japan (4 from Tokyo, 1 from Osaka),
and 1 each from Finland, Germany and South Korea. The 
16 firms that performed well on three dimensions shows
a similar trend in terms of industry representation, in-
cluding 10 electronics firms, 3 automobile manufacturers,
2 consumer products companies, and 1 pharmaceutical 
firm. Of these 16 firms, 8.5 came from USA, 3 from Ja-
pan, 1.5 from Germany, and 1 each from Korea, UK and 
the Netherlands. 
5.3. Comparisons with Business Week/BCG: 
Perceptions and Reality 
Surprisingly, among our top 15 firms that appeared in the
top 50 on all four of our innovation chain dimensions,
only 8 out of the 15 (53 percent) also appear in the Busi-
ness Week/BCG rankings of the top innovators. The 16
firms that performed well on at least three of our four 
dimensions fared slightly better on the Business Week/
BCG rankings (11 out of 16 firms, or 69 percent of them).
Among the most noteworthy firms that did well on our
quantitative measures but did not appear in Business 
Week/BCG’s more qualitative ranking were Bosch, Hi-
tachi, Nissan Motors, Sun Microsystems, and Toshiba
(see Appendix 4), all of which are foreign..
That anomaly aside, the perceptions of sitting CEO’s 
as captured in the Business Week/BCG ranking do not
match reality as well as one would expect. Our prior 
analysis of each of the four dimensions suggested that
the most overlap between our analysis and the Business
Week/BCG ranking occurred on the dimension of reve-
nues. As already suggested, the perceptions of sitting
CEO’s as to who are the most innovative firms is per-
haps influenced more by financial performance than in-
novation and commercialization. We find it interesting 
that there are firms that perform well on each of the di-
mensions of the innovation chain and, yet, do not appear
in the Business Week ranking. One explanation is that
these firms are successfully commercializing innovations,
but their reputation for being a great innovator does not
at doing this. Conversely, match their actual success
there are firms that appear on the Business Week ranking 
and do not appear on our lists. For example Ebay, Ama-
zon.com, or Google, despite not performing well on 
measures of the innovation chain were listed by CEOs as
being top innovators, perhaps because of the ubiquitous
presence of these firms or the innovative nature of their 
business models. 
We are not discounting organizations like Amazon’s
and Google’s innovative capacity; rather, we believe
they are not successful at commercializing innovations in
the classic sense as we measure it here. Amazon, Google, 
and Apple are organizations that are well known among 
CEOs and everyone else, while a company such as Fu-
jitso has products that rest deep inside a computer and
are not as well known. Similarly, the Business Week/
BCG ranking lists Walmart, Costco, and McDonalds as 
top innovative companies. While one can argue that
these firms might have innovative business models,
pricing strategies, or other tactics, the same cannot nec-
essarily be said of their ability to take their own new 
products to market. The point here is not that the Busi-
ness Week/BCG ranking is flawed or not useful. We
believe that their ranking is well done and very useful. 
On the one hand, while reputation is important, we be-
lieve that one should also consider hard measures of in-
novation and of commercialization. Equally, our more
quantitative measures do not tell the entire story. Ideally, 
a firm would need to perform well on all four dimensions
of the innovation chain and have a great reputation for
innovation. To do well on all of our four dimensions and
the Business Week/BCG ranking, as 9 firms did, could 
be considered the most comprehensive measure of suc-
cess. These firms are commercializing innovations suc-
cessfully and are well known for doing so.
5.4. Are We Missing Any Other Great
Innovators?
In our research we also uncovered a number of firms that
do not necessarily do well either in our analysis of the 
innovation chain or on Business Week’s ranking of top
innovators, and yet these firms are clearly innovative and 
creating value. These firms (Appendix 5) are not neces-
sarily spending lots of money on R & D, they are not
filing for lots of patents, they are not necessarily launch-
ing many new offerings, they do not have the scale in
revenues that some of the firms did in our analysis above,
but they are clearly very innovative firms that are adding
lots of value for consumers and to the economy at large.
They likely did not show up in our analysis simply be-
cause these firms are not making their own products in
the classic sense. These firms deserve a form of “honor-
able mention” in any treatise on firms that are good at 
commercializing innovation.
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6. Discussions 
6.1. Summary 
We found that R & D, Patenting and Product and Service
releases (CI) are tightly linked. However, the role that 
the three variables play with respect to Revenue was
slightly ambiguous. While the three variables collec-
tively explain variance in revenue, the paths from Patents 
and CI to revenue remained non significant. An interest-
ing observation is that as we moved forward to look at
revenues in subsequent years, the explanatory power of 
CI and Patents on Revenues increased. The explanation
for this is that there is a lag time from R & D spending to 
patents and from patents to commercialized products.
Also there is a lag time between product release and dif-
fusion of the product into the market [36]. These lag
times impact the effect of patents and, subsequently, 
product releases on revenues. Although statistically not
significant early on, the impact of patenting and com-
mercialization of innovations on revenues increases in
subsequent years. These investments appear to indeed 
pay off over time. 
6.2. Conclusions 
Being innovative is one of the key attributes to a firm’s
success. Business Week together with the Boston Con-
sulting Group identifies and ranks the top innovative 
firms, which provides a useful accounting each year of 
the best of the best. This annual list highlights in par-
ticular those top firms that have an excellent reputation 
for innovation. Through our research we aimed to sup-
plement the Business Week/BCG approach, and so we
looked specifically at the commercialization of innova-
tion. We focused on the innovation chain within compa-
nies and collected data on spending in R & D, patent
submissions, product/service releases, and revenues, and 
then showed who was the best at each of these criteria, 
and then across all of the criteria. 
Our approach shows that there are 15 firms that excel
at all four aspects of the innovation chain as we meas-
ured them, and another 16 firms that excel at three as-
pects. Perhaps not surprising, these top firms were
dominated by electronics manufacturers, although among 
the top firms were an airplane manufacturer, a software
firm, some consumer products firms, and a pharmaceuti-
cal giant. In any event, each of these firms is doing what
it takes to successfully commercialize innovation. Our 
approach was more quantitative in nature and measured
data on several key activities within the firm, and as a 
result our results differed from those from the 
qualitative approach taken by Business Week/BCG in 
more 
their ranking of innovative firms. There was just over 60 
percent overlap among top firms on our measures versus
those in the Business Week/BCG ranking. One puzzling
element to our data was that there was relatively little
overlap between our measure of product and service
launches and the Business Week measure of CEO per-
ceptions of innovation. We would have expected more
overlap on those two measures given how “public” prod-
uct launches can be. Perhaps not surprising, there was
greater overlap between our measure of revenues and the
Business Week measure of CEO perceptions of innova-
tion. That tells us that the perceptions of sitting CEOs as 
to who are the great innovators are driven by size and 
financial success. In any event, we believe that both our 
approach and the Business Week/BCG approach taken
together provide a useful look into how to be successful 
at innovating and to be well known for it. In addition, we 
provided some empirical evidence that activities toward
commercialization of innovation can impact revenues
downstream. We believe that collectively this work is not
only useful for those studying organizations, but for 
those working in, managing, directing, and investing in
them as well. 
6.3. Future Opportunities 
Like any other approach to research ours is not without
its own limits and weaknesses. Our approach does not,
for example, differentiate between product launches and 
significant product enhancements. It would be useful in
future to be able to distinguish between a new product
release like Windows Vista as opposed to enhancements 
like new service packs (i.e., incremental upgrades to the
Vista operating system). We could also in future distin-
guish better between types of products. For instance, a
release of a new mouse by Microsoft is not necessarily
the same as the release of a new model of airplane by 
Boeing. 
Another future path for this research would be to per-
form a causal, time-series analysis where one would look 
at R & D spending, patent protection, and new product/
service launches in one year and see how these variables 
influence revenues in subsequent years. Further, we
could control for macro-economic conditions, process
innovations, and a firm’s merger and acquisition activity 
to see what effect these have on commercialization of 
innovation versus the effect of our innovation chain 
variables. One other fruitful line of research may be to
determine what effect these real and perceived measures
of innovation and commercialization have on stock price,
which can be thought of as the market’s collective per-
ception of the value of a firm. We acknowledge that our 
research approach may be biased more toward firms that
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design, develop, and produce their own products, try to
protect them legally, and take them to market (i.e., clas-
sic manufacturing organizations). It is clear that a lot
remains to be done in helping us to better understand
commercialization of innovations, not only in terms of
better understanding the construct, but also in merging 
the gap between related perceptions and realities. This,
we believe, would also lead to a better understanding of
corporate reputation and help to understand why it is that
we believe some firms to be better than others at core
functions such as being innovative. We hope that our
work at least offers a good beginning and suggests some
fruitful avenues for future research. 
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Appendix 1
Top 50 organizations in the innovation chain.
Commercialization of R & D Ranking Patents RevenueInnovations (Business week(Business week Overlap = 44%) (Business week Overlap = 40%) (Business week Overlap = 48%) Overlap = 38%)
Rank
Patents R & D in Product Revenue inOrganization Organization Submitted in Organization Organization USD millions Launches USD millions 2007 
1 Pfizer 7600.18 IBM 3125 Microsoft 264 BP * 395062.85 
Samsung  2 Ford* 7205.67 2723 LG Electronics 246 Wal-Mart 351139.00 Electronics 
3 Johnson & Johnson 7145.42 CANON* 1983 Fujitso* 240 Exxon Mobil* 347254.00 
Matsushita Electric 
(Changed name to Freescale4 DaimlerChrysler 6903.09 1910 228 General Motors* 207349.00 Panasonic Semiconductor*
Corporation)* 
5 Toyota Motor 6821.32 Intel 1864 Toshiba* 226 DaimlerChrysler 203032.00 
6 GlaxoSmithKline* 6767.08 Microsoft 1637 Hewlett Packard 166 Toyota Motor 174905.73 
7 General Motors* 6635.17 Toshiba* 1519 Texas Instruments 156 GE 168307.00 
MICRON 
8 Seimens* 6626.12 TECHNOLOGY, 1476 Samsung Electronics 150 Ford* 160126.00 
INC.*
9 Microsoft 6155.20 Hewlett Packard 1466 STMicroelectronics* 144 VOLKSWAGEN 139802.76 
SHARP KABUSHIKI Samsung  10 6146.01 Sony 1454 KAISHA (SHARP 126 Seimens* 114243.47 Electronics CORPORATION)* 
11 Intel 5873.41 Hitachi* 1381 Sony 116 VERIZON 93221.00 
Advanced Micro Samsung  12 Sanofi-Aventis* 5808.41 Fujitso * 1293 107 91731.42 Devices* Electronics 
SEIKO EPSON13 IBM 5668.29 1205 General Motors* 105 Hewlett Packard 91658.00 CORPORATION* 
14 VOLKSWAGEN 5592.11 GE 911 Dell 98 IBM 91424.00 
Infineon  15 Roche* 5398.67 847 United Technologies* 94 NTT com* 89278.92 Technologies* 

Denso
16 Novartis* 5364.83 753 Oracle* 93 Nestle* 83573.78 Corporation* 
Texas  17 Nokia 4895.73 749 Nokia 88 Honda Motor 82387.45 Instruments*
RICOH18 merck 4776.20 727 Dow Chemical* 88 Nissan Motors* 79935.59 COMPANY, LTD.* 
Matsushita Electric 
(Changed name to 19 4740.73 Seimens 727 Hitachi* 87 Hitachi* 79074.85 Panasonic 

Corporation) * 

20 Robert Bosch* 4481.60 LG Electronics 682 Broadcom* 82 Peugot* 75489.48 
Matsushita Electric 
(Changed name to Sony 4463.87 Nokia21 679 Cisco Systems 81 74073.98 Panasonic 
Corporation)* 
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22 Honda Motor 4284.15 Honda Motor 677 Nortel Networks* 81 France Telecom* 70560.57 
23 BMW 4231.00 FujifilmCorporation 660 EMC* 75 Altria* 70324.00 
24 Cisco Systems 3987.76 
SHARP 
KABUSHIKI
KAISHA (SHARP 
CORPORATION)* 
646 
SUN 
MICROSYSTEMS, 
INC.*
72 BASF* 68651.13 
25 
Ericsson (aka: 
SONY ERICSSON 
MOBILE
CORPORATION)* 
3925.14 
SUN 
MICROSYSTEMS, 
INC.*
610 
Ericsson (aka: SONY 
ERICSSON MOBILE
CORPORATION) * 
71 Proctor and Gamble 68222.00 
26 AstraZeneca* 3902.59 Cisco Systems 580 SEIKO EPSONCORPORATION* 66 FIAT* 67894.65 
27 3M 3896.91 Robert Bosch* 568 Infineon Technologies* 66 Hundai* 67778.05 
BMW (AKA: 
28 EADS* 3783.91 ROYAL PHILIPS ELECTRONICS 547 Ford* 59 
BAYERISCHE 
MOTOREN 65092.33 
WERKE AG) 
29 Nissan Motors * 3756.97 Honeywell* 538 Caterpillar* 59 AT&T 63055.00 
30 Hewlett Packard 3574.66 Broadcom* 533 Electronic Arts* 59 Boeing 61530.00 
31 Hitachi* 3400.22 3M 459 Motorola 55 Target 59490.00 
32 AMGEN* 3367.25 Mitsubishi Electric* 459 RICOH COMPANY, LTD.* 55 Sony 57972.28 
33 Boeing 3261.09 Sanyo Electric* 454 Alcatel-Lucent** 53 Robert Bosch* 57456.42 
34 Bayer* 3240.53 Boeing 428 IBM 52 Dell 57095.00 
35 Renault* 3165.34 Motorola 411 EI du Pont de Nemours 52 Nokia 54397.00 
36 Eli Lilly* 3138.20 EI du Pont de Nemours* 369 Boeing 51 Unilever* 54314.42 
37 Toshiba* 3126.31 Toyota Motor 351 BT 50 Renault* 53649.79 
38 Wyeth* 3113.66 General Motors* 343 Johnson & Johnson 47 Johnson & Johnson 53324.00 
39 Bristol Meyers-Squibb* 3067.48 
Freescale
Semiconductor* 322 Robert Bosch 46 Toshiba* 52988.22 
Matsushita Electric 
40 GE* 3029.53 Ford* 315 (Changed name to Panasonic 45 Pfizer 52415.00 
Corporation)* 
41 Peugot* 2868.60 Advanced Micro Devices* 304 GlaxoSmithKline* 44 EADS* 51834.36 
42 Alcatel-Lucent* 2621.96 Applied Materials* 285 3M 42 LG Elecronics 49876.58 
SUN 
43 MICROSYSTEMS, 2600.53 Genentech* 281 SAP* 42 Dow Chemical 49124.00 
INC.*
44 NTT com* 2589.09 Qualcomm* 278 Intel 38 United Technologies* 47829.00 
45 CANON * 2587.91 AT&T 273 Novartis* 36 GlaxoSmithKline* 45416.65 
46 ROYAL PHILIPS ELECTRONICS 2569.20 Nortel Networks* 272 Toyota Motor 35 Microsoft 44282.00 
47 Finmeccanica* 2465.00 Nissan Motors * 268 DaimlerChrysler 34 Motorola 43739.00 
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48 BAE Systems* 2442.96 Medtronic* 250 AT&T 34 Bayer* 42084.75 
49 Abbott Laboratories* 2247.63 Lockheed Martin* 240 GE 33 Caterpillar* 41517.00 
50 Texas Instruments* 2194.50 BASF* 224 Proctor and Gamble 32 ROYAL PHILIPS ELECTRONICS 40780.96 
51 Schering-Plough* 7600.18 Proctor and Gamble 215 Sanofi-Aventis* 32 Fujitso* 40553.94 
Appendix 2
 
Positioning of organizations in the innovative chain.
 
LEGEND 
Appeared in 4 lists 
Appeared in 3 lists 
Appeared in 2 lists 
Appeared Just once 
By R & D Spending By Patents By commercialization of Innovations Revenue 
3M 3M 3M BP 
Abbott Laboratories Advanced Micro Devices Advanced Micro Devices Altria 
Alcatel-Lucent Applied Materials Alcatel-Lucent** AT&T 
AMGEN AT&T AT&T BASF 
AstraZeneca BASF Boeing Bayer 
BAE Systems Boeing Broadcom BMW (AKA: BAYERISCHE MOTOREN WERKE AG)
Bayer Broadcom BT Boeing 
BMW (AKA: BAYERISCHE 
MOTOREN WERKE AG) CANON Caterpillar Caterpillar 
Boeing Cisco Systems Cisco Systems DaimlerChrysler 
Bristol Meyers-Squibb Denso Corporation DaimlerChrysler Dell 
CANON EI du Pont de Nemours Dell Dow Chemical 
Cisco Systems Ford Dow Chemical EADS 
DaimlerChrysler Freescale Semiconductor EI du Pont de Nemours Exxon Mobil 
EADS Fujifilm Corporation Electronic Arts FIAT 
Eli Lilly Fujitso EMC Ford 
Ericsson (aka: SONY ERICSSON 
MOBILE CORPORATION) GE 
Ericsson (aka: SONY ERICSSON 
MOBILE CORPORATION) France Telecom
Finmeccanica Genentech Ford Fujitso 
Ford General Motors Freescale Semiconductor GE 
Hewlett Packard Fujitso General Motors 
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General Motors Hitachi GE GlaxoSmithKline
GlaxoSmithKline Honda Motor General Motors Hewlett Packard 
Hewlett Packard Honeywell GlaxoSmithKline Hitachi 
Hitachi IBM Hewlett Packard Honda Motor
Honda Motor Infineon Technologies Hitachi Hundai 
IBM Intel IBM IBM 
Intel LG Elecronics Infineon Technologies Johnson & Johnson 
Johnson & Johnson Lockheed Martin Intel LG Electronics 
Matsushita Electric (Changed name Matsushita Electric (Changed name Matsushita Electric (Changed nameJohnson & Johnson to Panasonic Corporation) to Panasonic Corporation) to Panasonic Corporation)
merck Medtronic LG Electronics Microsoft 
Microsoft MICRON TECHNOLOGY, INC. Matsushita Electric (Changed nameto Panasonic Corporation) Motorola 
Nissan Motors Microsoft Microsoft Nestle 
Nokia Mitsubishi Electric Motorola Nissan Motors 
Novartis Motorola Nokia Nokia 
NTT com Nissan Motors Nortel Networks NTT com
Peugot Nokia Novartis Peugot 
Pfizer Nortel Networks Oracle Pfizer 
Renault Proctor and Gamble Proctor and Gamble Proctor and Gamble 
Robert Bosch Qualcomm RICOH COMPANY, LTD. Renault 
Roche RICOH COMPANY, LTD. Robert Bosch Robert Bosch 
ROYAL PHILIPS ELECTRONICS Robert Bosch Samsung Electronics ROYAL PHILIPS ELECTRONICS 
Samsung Electronics ROYAL PHILIPS ELECTRONICS Sanofi-Aventis Samsung Electronics 
Sanofi-Aventis Samsung Electronics SAP Seimens 
Schering-Plough Sanyo Electric SEIKO EPSON CORPORATION Sony
Seimens SEIKO EPSON CORPORATION SHARP KABUSHIKI KAISHA (SHARP CORPORATION) Target 
Sony Seimens Sony Toshiba 
SUN MICROSYSTEMS, INC. SHARP KABUSHIKI KAISHA (SHARP CORPORATION) STMicroelectronics Toyota Motor 
Texas Instruments Sony SUN MICROSYSTEMS, INC. Unilever 
Toshiba SUN MICROSYSTEMS, INC. Texas Instruments United Technologies 
Toyota Motor Texas Instruments Toshiba VERIZON  
VOLKSWAGEN Toshiba Toyota Motor VOLKSWAGEN
Wyeth Toyota Motor United Technologies Wal-Mart 
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Appendix 3
Organizations consistent with all (or most aspects of) the innovation chain.
Organizations appeared in all aspects of innovation value chain 
Commercialization R & D Spend- Considered ByName Patents Revenue Geographic Locations of Innovations ing Business Week 
Boeing Yes Yes Yes Yes Yes Seattle, WA, USA
Ford Yes Yes Yes Yes NO Dearborn, MI, USA 
General Motors Yes Yes Yes Yes NO Detroit, MI, USA
Hewlett Packard Yes Yes Yes Yes Yes Palo Alto, CA, USA 
Hitachi Yes Yes Yes Yes 0 Tokyo, Japan 
IBM Yes Yes Yes Yes Yes Armonk, NY, USA 
Matsushita Electric (Changed name to Yes Yes Yes Yes NO Osaka, Japan Panasonic Corporation)
Microsoft Yes Yes Yes Yes Yes Redmond, WA, USA 
Motorola Yes Yes Yes Yes Yes Schaumburg, Il, USA 
Nokia Yes Yes Yes Yes Yes Espoo, Finland 
Robert Bosch Yes Yes Yes Yes NO Gerlingen, Germany 
Samsung Electronics Yes Yes Yes Yes Yes Seoul, South Korea 
Sony Yes Yes Yes Yes Yes Tokyo, Japan 
Toshiba Yes Yes Yes Yes NO Tokyo, Japan 
Toyota Motor Yes Yes Yes Yes Yes Tokyo, Japan 
Organizations appeared in three out of four aspects of innovation value chain 
Commercialization R & D Spend- Considered ByName Patents Revenue Geographic Locations of Innovations ing Business Week 
3M Yes Yes Yes No Yes Maplewood, MN, USA 
AT&T Yes Yes No Yes Yes Dallas, TX, USA
Cisco Systems Yes Yes Yes No Yes San Jos, CA, USA
Chrysler  Auburn Hills, 
DaimlerChrysler Yes No Yes Yes Yes MI, USA Daimler
Stuttgart Germany 
Fujitso Yes Yes No Yes No Tokyo, Japan 
GlaxoSmithKline Yes No Yes Yes Yes London, UK 
Honda Motor Yes Yes Yes Yes Yes Tokyo, Japan 
Intel Yes Yes Yes No Yes Santa Clara, CA, USA 
Johnson & Johnson Yes No Yes Yes Yes New Brunswick, NJ, USA 
LG Elecronics Yes Yes Yes Yes Yes Seoul, South Korea 
Nissan Motors Yes Yes No Yes No Tokyo, Japan 
Procter and Gamble Yes Yes No Yes Yes Cincinnati, OH, USA 
ROYAL PHILIPS ELECTRONICS No Yes Yes Yes Yes Amsterdam, Netherlands 
Seimens No Yes Yes Yes No Berlin and Munich, Germany 
Yes Yes Yes Yes No Santa Clara, CA, USA 
Yes Yes Yes No No Dallas, TX, USA
SUN MICROSYSTEMS, INC. 
Texas Instruments
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Appendix 4
Innovative firms that are not ranked by Business Week. 
Some top innovative firms that are not ranked by Business Week
Hitachi 

With an approximate R & D investment of $3.4 billion, Hitachi is ranked at 31 in terms of R & D Spending. With 1381 patent submissions, it is
 
ranked 11th in terms of patent protection. From January 2007 through June 2008 it has released about 90 products (enhancements and new re-
leases), positioned at 18th in terms of product launches. With revenue around $80 billion, it is ranked at 19th. 

Nissan Motors: 

With an approximate R & D investment of $3.7billion, Nissan is ranked at 29in terms of R & D Spending. With 268 patent submissions, Nissan is
 
ranked at 47 in terms of patents. With only 30 product releases Nissan did not reach our top 50 in terms of product launches. With revenue around 

$80 billion, it is ranked at 18th. 

Robert Bosch 

With an approximate R & D investment of $4.4 billion, Robert Bosch is ranked at 20 in terms of R & D Spending. With 568 patent submissions, 

it is ranked 27th in terms of patent protection. From January 2007 through June 2008 it has released about 46 products (enhancements and new 

releases), positioned at 39th in terms product launches. With revenue exceeding $57 billion, it is ranked at 33rd. 

Sun Microsystems
 
With an approximate R & D investment of $2.6 billion, Sun Microsystems is ranked at 43 in terms of R & D Spending. With 610 patent submis-
sion, it is ranked 25th in terms of patent protection. From January 2007 through June 2008 it has released about 46 products (enhancements and
 
new releases), positioned at 39thh in terms of product launches. Sun Microsystems did not feature in our top 50 revenue generating organizations, 

with revenue of $13 billion. 

Toshiba 

With an approximate R & D investment of $3.1 billion, Toshiba at 37 in terms of R & D Spending. With 1519 patent submission, it is ranked 7th
 
in terms of patent protection. From January 2007 through June 2008 it has released about 225 products (enhancements and new releases), posi-
tioned at 5th in terms of product launches. With revenue around 53 billion, it is ranked at 39th. 

TI
                                                                              
 
 
 
 
      
   
  
 
  
  
 
  
        
   
   
  
   
    
 
   
  
 
 
  
 
 
 
 
 
 
272
Appendix 5
Innovative firms not captured by our rankings. 
Some innovative companies not listed in our rankings
Google 
Headquartered in Menlo Park, CA, and with annual revenues now approximately $22 billion, Google revolutionized web search. Not only has it 
made search ubiquitous but it has also transformed the revenue models surrounding search engines. In addition to its own research and development,
Google also acquired the companies below in order to bring search engines, weather information, news, and social networking all under the same
umbrella. With these acquisitions Google is increasing the depth and breadth of search engines to include news, video, people, products, Web 2.0
and much more. All has helped the word “Google” to become synonymous with search.
1) Keyhole, Inc., led to the development of Google Earth 
2) YouTube., Online Video posting and viewing site 
3) JotSpot., a developer of wiki technology for collaborative Web sites 
4) GrandCentral. Internet service that uses voice over internet protocol (VoIP) to link customers’ phone numbers together.
5) Orkut, Google+. Social Networking site.
6) Andriod: Mobile Operating System
IDEO 
IDEO may physically produce and launch its own physical “products,” but they certainly help others to innovate. Based out of Palo Alto, CA,
IDEO has worked on thousands of projects for a large number of clients in the consumer, computer, medical, furniture, toy, office and automotive
industries. Notable examples are Apple’s first mouse, Microsoft’s second mouse, the Palm V PDA, and Steelcase’s Leap Chair. Major clients (as 
of 2004) included Procter & Gamble, PepsiCo, Microsoft, Eli Lilly, and Steelcase. 
Amazon.com
Based in Seattle, WA, and with annual revenue crossing the $19 billion mark in 2008, Amazon.com is the largest online retailer in the world.
Credit goes toAmazon.com in popularizing online shopping, to the extent that it the most used platform for product purchase and feature lookups. On
November 19, 2007, Amazon released its first product, the Amazon Kindle. The device used E Ink brand electronic paper displays and enables
users to download content over Amazon Whispernet using the Sprint EVDO Network. On March 3, 2009, Amazon. com launched Kindle for
iPhone in the App Store for iPhone and iPod Touch owners to read Kindle content. Through a technology termed “Whispersync,” customers can
keep their place across Kindle hardware devices and other mobile devices. Amazon announced the Kindle DX on May 6, 2009. This device has a 
larger screen than its predecessors and supports PDF files natively. It is marketed as more suitable for displaying newspaper and textbook content. 
There are many other innovative services (not products) offered by Amazon.com, such as A9.com, Alexa Internet, IMDb, and Amazon Web
Services.
Ebay 
Based out of San Jose, CA, and with revenues over $8 billion annually, EBay is certainly responsible for the adoption and diffusion of online
auctioning. They also combined online auctioning with new services such as “buy it now”. EBay has also established localized websites in thirty
countries other than the United States. Ebay also owns Paypal, a trusted name in facilitating online payments. Other acquisitions of EBay include: 
Skype, StubHub (an online marketplace for buyers and sellers of tickets for sports, concerts, theater and other live entertainment events at fair
market value, even for events that happen to be sold out), and Kijiji (a centralized network of online urban communities for posting local online 
classified advertisements). 
TI
